ENVERIC BIOSCIENCES INC (ENVB) Stock Balance Sheet
NASDAQ:ENVB • US29405E5050
Current stock price
1.88 USD
+0.02 (+1.08%)
At close:
1.8001 USD
-0.08 (-4.25%)
After Hours:
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.76M | 2.24M | 2.29M | N/A | N/A | |||
| Cash Equivalents | N/A | N/A | N/A | 17.72M | 17.36M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 407.90K | 493.60K | 1.29M | 710.00K | 380.00K | |||
| Total Current Assets | 4.17M | 2.73M | 3.58M | 18.43M | 17.74M | |||
| Non-Current Assets | ||||||||
| PPE Net | 196.50K | 305.80K | 507.40K | 740.00K | 470.00K | |||
| Goodwill | N/A | N/A | N/A | 0.00 | 1.59M | |||
| Intangibles | N/A | 42.20K | 210.90K | 380.00K | 6.92M | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 196.60K | 347.90K | 718.30K | 1.12M | 8.98M | |||
| TOTAL ASSETS | 4.36M | 3.08M | 4.30M | 19.55M | 26.72M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | N/A | |||
| Accrued Expenses | 220.30K | 732.00K | 1.08M | 1.77M | 1.40M | |||
| Accounts Payable | 683.70K | 521.80K | 1.22M | 460.00K | 680.00K | |||
| Other Current Liabilities | 1.90K | 236.00K | 49.10K | 1.76M | N/A | |||
| Total Current Liabilities | 905.90K | 1.49M | 2.34M | 4.00M | 2.08M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 0.00 | 1.61M | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | 0.00 | 720.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 880.00K | 2.33M | |||
| TOTAL LIABILITIES | 905.90K | 1.49M | 2.34M | 4.88M | 4.41M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -112.65M | -106.07M | -96.50M | -79.21M | -60.74M | |||
| Additional Paid In Capital | 116.68M | 108.26M | 100.82M | 94.40M | 82.75M | |||
| Minority Interest | N/A | N/A | N/A | 890.00K | N/A | |||
| Common Shares | 5.20K | 6.80K | 27.40K | 20.00K | 330.00K | |||
| Other Shareholders' Equity | -581.00K | -594.50K | -2.39M | -540.00K | -30.00K | |||
| Shares Outstanding | 218.30K | 56.50K | 15.20K | 11.60K | 3.60K | |||
| Tangible Book Value per Share | 15.83 | 27.44 | 114.68 | 1.24K | 3.81K | |||
| Total Shareholders' Equity | 3.46M | 1.59M | 1.96M | 14.67M | 22.31M | |||
| TOTAL LIABILITIES AND EQUITY | 4.36M | 3.08M | 4.30M | 19.55M | 26.72M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 4.60 | 1.84 | 1.53 | 4.61 | 8.53 | |||
| Return On Assets (ROA) | -257.81% | -310.46% | -395.37% | -96.16% | -183.31% | |||
| Return On Equity (ROE) | -325.39% | -600.83% | -868.99% | -128.15% | -219.54% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21